These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38366191)

  • 1. Injury minimization after myocardial infarction: focus on extracellular vesicles.
    Barile L; Marbán E
    Eur Heart J; 2024 May; 45(18):1602-1609. PubMed ID: 38366191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Efficacy of Cryopreserved, Allogeneic Extracellular Vesicles for Treatment of Acute Myocardial Infarction.
    Chung JJ; Kim ST; Zaman S; Helmers MR; Arisi MF; Li EC; Tran Z; Chen CW; Altshuler P; Chen M; Burdick JA; Atluri P
    Int Heart J; 2021 Mar; 62(2):381-389. PubMed ID: 33731514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
    Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
    Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles derived from myocardial infarction plasma inhibit BMSCs apoptosis and enhance cardiac function via AKT signaling pathway.
    Jin P; Ding L; Wang L; Jiang S; Weng J; Gao Y; Fan J; Sun LZ
    Int Immunopharmacol; 2021 Jul; 96():107730. PubMed ID: 34020395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.
    Firoozi S; Pahlavan S; Ghanian MH; Rabbani S; Barekat M; Nazari A; Pakzad M; Shekari F; Hassani SN; Moslem F; Lahrood FN; Soleimani M; Baharvand H
    Biochem Biophys Res Commun; 2020 Apr; 524(4):903-909. PubMed ID: 32057366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic Stem Cell-Derived Extracellular Vesicles for Cardiac Repair in Preclinical Animal Models of Myocardial Infarction: A Meta-Analysis.
    Gao Y; Wu D; Jia D; Guo Q; Wang M; Yang R; Zhang X; Chen M; Zhang D
    Stem Cells Dev; 2021 Sep; 30(18):891-907. PubMed ID: 34271845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface engineering enhances the therapeutic potential of systemically delivered extracellular vesicles following acute myocardial infarction.
    Mentkowski KI; Tarvirdizadeh T; Manzanero CA; Eagler LA; Lang JK
    FASEB J; 2024 Sep; 38(18):e70070. PubMed ID: 39301939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition.
    Huang G; Cheng Z; Hildebrand A; Wang C; Cimini M; Roy R; Lucchese AM; Benedict C; Mallaredy V; Magadum A; Joladarashi D; Thej C; Gonzalez C; Trungcao M; Garikipati VNS; Elrod JW; Koch WJ; Kishore R
    Theranostics; 2022; 12(9):4415-4430. PubMed ID: 35673580
    [No Abstract]   [Full Text] [Related]  

  • 9. Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol.
    Tieu A; Slobodian M; Fergusson DA; Montroy J; Burger D; Stewart DJ; Shorr R; Allan DS; Lalu MM
    Syst Rev; 2019 Dec; 8(1):322. PubMed ID: 31831057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Inflammation after Myocardial Infarction: A Therapeutic Opportunity for Extracellular Vesicles?
    Viola M; de Jager SCA; Sluijter JPG
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors.
    El Harane N; Kervadec A; Bellamy V; Pidial L; Neametalla HJ; Perier MC; Lima Correa B; Thiébault L; Cagnard N; Duché A; Brunaud C; Lemitre M; Gauthier J; Bourdillon AT; Renault MP; Hovhannisyan Y; Paiva S; Colas AR; Agbulut O; Hagège A; Silvestre JS; Menasché P; Renault NKE
    Eur Heart J; 2018 May; 39(20):1835-1847. PubMed ID: 29420830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.
    Ophelders DR; Wolfs TG; Jellema RK; Zwanenburg A; Andriessen P; Delhaas T; Ludwig AK; Radtke S; Peters V; Janssen L; Giebel B; Kramer BW
    Stem Cells Transl Med; 2016 Jun; 5(6):754-63. PubMed ID: 27160705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell-derived extracellular vesicles for myocardial infarction: a meta-analysis of controlled animal studies.
    Yang L; Zhu J; Zhang C; Wang J; Yue F; Jia X; Liu H
    Aging (Albany NY); 2019 Feb; 11(4):1129-1150. PubMed ID: 30792374
    [No Abstract]   [Full Text] [Related]  

  • 14. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis.
    Wu Q; Wang J; Tan WLW; Jiang Y; Wang S; Li Q; Yu X; Tan J; Liu S; Zhang P; Tiang Z; Chen Z; Foo RS; Yang HT
    Cell Death Dis; 2020 May; 11(5):354. PubMed ID: 32393784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.
    Hocine HR; Brunel S; Chen Q; Giustiniani J; San Roman MJ; Ferrat YJ; Palacios I; de la Rosa O; Lombardo E; Bensussan A; Charron D; Jabrane-Ferrat N; Al-Daccak R
    Stem Cells Transl Med; 2019 Sep; 8(9):911-924. PubMed ID: 30924311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death.
    Khandagale A; Lindahl B; Lind SB; Shevchenko G; Siegbahn A; Christersson C
    Curr Res Transl Med; 2022 May; 70(2):103323. PubMed ID: 34979484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles enriched with miR-150 released by macrophages regulates the TP53-IGF-1 axis to alleviate myocardial infarction.
    Zheng S; Gong M; Chen J
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H969-H979. PubMed ID: 33164579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of βARKct engineered cellular extracellular vesicles and model specific cardioprotection.
    Kwon JS; Schumacher SM; Gao E; Chuprun JK; Ibetti J; Roy R; Khan M; Kishore R; Koch WJ
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1276-H1289. PubMed ID: 33513081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving Strategies for Extracellular Vesicles as Future Cardiac Therapeutics: From Macro- to Nano-Applications.
    Guerricchio L; Barile L; Bollini S
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
    Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
    Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.